Patient 2, diagnosed at age 52, had hormone-positive/HER2-negative ductal-lobular carcinoma and received lumpectomy, hormonal therapy, and target therapy. The gene discussed is ERBB2; the disease is mixed lobular and ductal breast carcinoma.